Oral re-vaccination of Eurasian wild boar with Mycobacterium bovis BCG yields a strong protective response against challenge with a field strain

BACKGROUND: Field vaccination trials with Mycobacterium bovis BCG, an attenuated mutant of M. bovis, are ongoing in Spain, where the Eurasian wild boar (Sus scrofa) is regarded as the main driver of animal tuberculosis (TB). The oral baiting strategy consists in deploying vaccine baits twice each su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gortazar, Christian, Beltrán-Beck, Beatriz, Garrido, Joseba M, Aranaz, Alicia, Sevilla, Iker A, Boadella, Mariana, Lyashchenko, Konstantin P, Galindo, Ruth C, Montoro, Vidal, Domínguez, Lucas, Juste, Ramón, de la Fuente, Jose
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4005810/
https://ncbi.nlm.nih.gov/pubmed/24766746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-6148-10-96
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars